NTF3 and Parkinson disease: This review aims to explore the ability of ZnO-NPs to modulate key pathological pathways underlying PD, including neurotrophic factor expression, inhibit fibril formation of aggregation-prone protein, reduce oxidative stress, suppress inflammation, and mitigate neuronal apoptosis.